- Home
- TNGX vs BRY Comparison
TNGX vs BRY Comparison
Compare TNGX & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- BRY
- Stock Information
- Founded
- TNGX 2014
- BRY 1909
- Country
- TNGX United States
- BRY United States
- Employees
- TNGX N/A
- BRY N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- TNGX Health Care
- BRY Energy
- Exchange
- TNGX Nasdaq
- BRY Nasdaq
- Market Cap
- TNGX 351.2M
- BRY 186.1M
- IPO Year
- TNGX N/A
- BRY N/A
- Fundamental
- Price
- TNGX $6.01
- BRY $3.24
- Analyst Decision
- TNGX Strong Buy
- BRY Buy
- Analyst Count
- TNGX 6
- BRY 2
- Target Price
- TNGX $12.20
- BRY $5.00
- AVG Volume (30 Days)
- TNGX 2.7M
- BRY 1.2M
- Earning Date
- TNGX 08-06-2025
- BRY 08-08-2025
- Dividend Yield
- TNGX N/A
- BRY 3.71%
- EPS Growth
- TNGX N/A
- BRY N/A
- EPS
- TNGX N/A
- BRY N/A
- Revenue
- TNGX $40,990,000.00
- BRY $753,737,000.00
- Revenue This Year
- TNGX N/A
- BRY N/A
- Revenue Next Year
- TNGX N/A
- BRY $0.96
- P/E Ratio
- TNGX N/A
- BRY N/A
- Revenue Growth
- TNGX 10.09
- BRY N/A
- 52 Week Low
- TNGX $1.03
- BRY $2.11
- 52 Week High
- TNGX $12.02
- BRY $7.02
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- BRY 59.14
- Support Level
- TNGX $5.34
- BRY $3.13
- Resistance Level
- TNGX $6.40
- BRY $3.12
- Average True Range (ATR)
- TNGX 0.50
- BRY 0.17
- MACD
- TNGX -0.02
- BRY 0.02
- Stochastic Oscillator
- TNGX 84.08
- BRY 78.79
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.